In a groundbreaking achievement, researchers at the CRCHUM, the hospital research center affiliated with Université de Montréal, have identified a type of microRNA that can safeguard small blood vessels and help maintain kidney function following severe injury.

This discovery holds significant promise for the more than four million Canadians living with chronic renal failure, as well as millions of patients worldwide, by offering new possibilities for earlier detection and prevention of the disease.

Until now, there had been no dependable biomarker to assess the condition of these delicate capillaries or to guide targeted strategies aimed at protecting kidney function.